These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30426948)

  • 1. Surgery in patients with congenital factor VII deficiency - a single center study.
    Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
    Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
    Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
    Mariani G; Dolce A; Batorova A; Auerswald G; Schved JF; Siragusa S; Napolitano M; Knudsen JB; Ingerslev J;
    Br J Haematol; 2011 Feb; 152(3):340-6. PubMed ID: 21158750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
    Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
    Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
    Yilmaz AA; Yalcin S; Serdaroglu H; Sonmezer M; Uysalel A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):693-5. PubMed ID: 18832912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
    Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
    Scharrer I
    Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
    Karimi M
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.
    Niikura T; Nishikawa T; Saegusa Y; Fujishiro T; Yoshiya S; Kurosaka M
    J Arthroplasty; 2005 Apr; 20(3):396-400. PubMed ID: 15809961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Surgical Third Lower Molar Extraction and Postoperative Progress in Patients With Factor VII Deficiency: A Clinical Protocol and Focus on This Rare Pathologic Entity.
    Passarelli PC; Pasquantonio G; D'Addona A
    J Oral Maxillofac Surg; 2017 Oct; 75(10):2070.e1-2070.e4. PubMed ID: 28672139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
    Sun Y; Jia L; Yang Z; Chen W
    Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
    van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
    Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.